{"id":"n_7cjzuajf3nxdrwyamuia","seq":9716827,"kind":"article","title":"Korea warns of rare vision-loss risk linked to GLP-1 drugs","url":"https://www.koreatimes.co.kr/southkorea/society/20261111/korea-warns-of-rare-vision-loss-risk-linked-to-glp-1-drugs","summary":"The Ministry of Food and Drug Safety issued a safety alert Wednesday to medical professionals and patients over a potential risk of a rare eye condition associated with GLP-1 obesity drugs, including popular obesity treatments Wegovy and Mounjaro. The move follows safety measures by overseas regulators concerning nonarteritic anterior ischemic optic neuropathy (NAION), a condition caused by reduced blood flow to the optic nerve that can lead to sudden, potentially permanent…","published":"2026-11-11T04:57:03Z","seen":"2026-11-11T05:02:00Z","lang":"en","source":{"id":"kite-koreatimes-co-kr-c6eccf","name":"koreatimes.co.kr","domain":"feed.koreatimes.co.kr"},"via":"kite-koreatimes-co-kr-c6eccf","topics":["asia"],"authors":["author"],"image":"https://newsimg.koreatimes.co.kr/2026/11/11/f94f082d-7715-4f89-880e-2be99fbbfe3b.jpg","mentions":2,"story":"st_mve5oebxpsurwqsjtw2q","category":"health","category_p":0.67,"sentiment":"negative","tone":-0.68,"political":0.33}